Back
PubMedNew toolBenchmark

SPLENDID incorporates continuous genetic ancestry in biobank-scale data to improve polygenic risk prediction across diverse populations.

Chen T, Zhang H, Mazumder R, et al.Nat Methods 2026 · September 2026
Relevance score
8/10
Disease / domain
Polygenic risk prediction across diverse populations
Source
PubMed
PMID 42736360

Tool / method

Penalized regression on biobank-scale individual-level data, modelling genetic ancestry as a continuum

Summary

SPLENDID is a penalized regression framework for biobank-scale individual-level data that models genetic ancestry as a continuum, without labelling individuals by ancestry group. It produces a single prediction model, removing the practical requirement to assign every person to a pre-specified ancestry category — a step poorly suited to clinical decision-making and impossible for many admixed individuals. In extensive simulations and in the All of Us Research Program (n = 224,364) and UK Biobank (n = 340,140), SPLENDID significantly improved prediction accuracy over existing methods, particularly for non-European and admixed ancestries.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

The problem with polygenic risk scores is not only transferability: applying a model requires slotting the patient into an ancestry category, which no clinical encounter actually does. A single continuous model is the right methodological answer, validated here in two biobanks of over 200,000 participants each. What is missing is the one thing that would decide clinical use: reclassification metrics against a real decision — screening threshold, age at which surveillance starts — rather than a gain in prediction accuracy.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 2/3Evidence 2/3Novelty 2/2Sample 1/1Publication 1/1

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 2/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 8/10

Keywords

PRSpolygenic risk scoregenetic ancestrybiobankrisk stratification
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime